Steve Deitsch

Steve Deitsch is the current Senior Vice President, Chief Financial Officer & Treasurer at BioScrip. Prior to joining BioScrip, Steve held several senior finance positions at companies such as Auddia, Paragon 28, Green Sun Medical, and Coalfire.

Steve began their career at Ernst & Young in 2001 as a Senior Manager. In 2002, they joined Zimmer as Vice President of Finance for Global Reconstructive & Global Operations. Steve held this position until 2009 when they were promoted to Chief Financial Officer of Lanx, a Biomet company. In 2014, they became the CAO/Corporate Controller of Biomet prior to its merger with Zimmer in 2015.

As CFO of Biomet Group Spine, Bone Healing, and Microfixation, Steve was responsible for the financial component of the merger with Zimmer. Steve continued to serve as CFO/Treasurer of Zimmer Biomet until 2017 when they joined BioScrip.

Steve Deitsch's educational career began when they earned their BS in Accounting from Ball State University.

Steve Deitsch reports to Daniel E. Greenleaf, President & CEO. They work with Bob Roose - SVP, Chief Procurement Officer, Rich Denness - SVP, Chief Commercial Officer, and Harriet Booker - SVP & COO.